Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
ADIL Adial Pharmaceuticals
- 1.0700
- +0.0200+1.90%
Close Dec 20 16:00 ET
- 1.0500
- -0.0200-1.87%
Post 19:48 ET
6.85MMarket Cap-0.32P/E (TTM)
1.0700High1.0000Low144.27KVolume1.0400Open1.0500Pre Close147.68KTurnover2.42%Turnover RatioLossP/E (Static)6.41MShares4.169952wk High1.17P/B6.37MFloat Cap0.765052wk Low--Dividend TTM5.95MShs Float236.0000Historical High--Div YieldTTM6.67%Amplitude0.7650Historical Low1.0230Avg Price1Lot Size
About Adial Pharmaceuticals Company
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.
Company Profile
SymbolADIL
Company NameAdial Pharmaceuticals
Listing DateJul 27, 2018
Founded2010
CEOMr. Cary J Claiborne
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address4870 Sadler Road,Suite 300
CityGlen Allen
ProvinceVirginia
CountryUnited States of America
Zip Code23060
Phone1-434-487-8196
Websitehttp://www.adialpharma.com
Company Executives
- Name
- Position
- Salary
- Cary J Claiborne
- Director, President and Chief Executive Officer
- 801.62K
- Tony Goodman
- Director and Chief Operating Officer
- 261.93K
- Vinay Shah
- Chief Financial Officer
- --
- Kevin Schuyler, C.F.A.,M.B.A.
- Chairman of the Board and Lead Independent Director
- 60.22K
- J. Kermit Anderson
- Independent Director
- 59.22K
- Robertson H. Gilliland, M.B.A.
- Independent Director
- 53.22K
- James W. Newman, Jr
- Independent Director
- 56.22K